Tania H Watts Selected Research

Tania H Watts Research Topics

Disease

19	Infections 01/2023 - 04/2002
14	Human Influenza (Influenza) 01/2023 - 04/2002
7	Neoplasms (Cancer) 11/2023 - 01/2005
7	Virus Diseases (Viral Diseases) 01/2023 - 06/2008
5	Persistent Infection 01/2018 - 12/2007
4	Rheumatoid Arthritis 01/2023 - 01/2017
2	Ankylosing Spondylitis 01/2023 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2022
2	Lymphoma (Lymphomas) 01/2021 - 03/2002
2	Lymphocytic Choriomeningitis 12/2018 - 01/2018
2	Inflammation (Inflammations) 12/2018 - 01/2017
2	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2017
1	Lung Injury 01/2023
1	Psoriatic Arthritis 01/2023
1	Edema (Dropsy) 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	COVID-19 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Chylous Ascites 05/2019
1	Wasting Syndrome (Wasting Disease) 05/2019
1	HIV Infections (HIV Infection) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Confusion (Bewilderment) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017
1	Splenomegaly 11/2014
1	Berylliosis 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2005
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2005
1	Communicable Diseases (Infectious Diseases) 01/2005
1	Myocarditis (Carditis) 12/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2003

Drug/Important Bio-Agent (IBA)

7	TNF Receptor-Associated Factor 1IBA 01/2021 - 06/2008
6	AntibodiesIBA 11/2023 - 05/2006
5	AntigensIBA 01/2019 - 07/2003
4	Peptides (Polypeptides)IBA 01/2021 - 03/2002
4	LigandsIBA 12/2018 - 09/2013
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017 - 06/2010
3	CytokinesIBA 01/2022 - 11/2005
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
3	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2018 - 01/2009
3	4-1BB Ligand (4 1BB Ligand)IBA 08/2011 - 04/2002
2	Immunoglobulin G (IgG)IBA 01/2015 - 05/2006
2	Type II Tumor Necrosis Factor ReceptorsIBA 09/2013 - 01/2013
2	EpitopesIBA 01/2013 - 11/2005
2	VaccinesIBA 08/2011 - 01/2011
1	OccludinIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	InterferonsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Protein Kinase CIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Chemokine ReceptorsIBA 11/2020
1	Glucocorticoid-Induced TNFR-Related ProteinIBA 01/2020
1	MethylcholanthreneIBA 05/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 05/2019
1	Viral AntigensIBA 12/2018
1	Insulin ReceptorIBA 12/2018
1	Fc Receptors (Fc Receptor)IBA 11/2018
1	5' Untranslated Regions (5' UTR)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	CD30 LigandIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Interferon Type IIBA 01/2016
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	Alanine Transaminase (SGPT)IBA 11/2014
1	Viral VaccinesIBA 09/2013
1	Interleukin-7 (Interleukin 7)IBA 01/2012
1	NucleoproteinsIBA 08/2011
1	Adenovirus VaccinesIBA 08/2011
1	Inactivated VaccinesIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	LectinsIBA 01/2011
1	BerylliumIBA 09/2008
1	Programmed Cell Death 1 ReceptorIBA 12/2007
1	Antiviral Agents (Antivirals)IBA 11/2005
1	Amino Acids FDA Link 08/2005
1	AutoantibodiesIBA 09/2003
1	DNA (Deoxyribonucleic Acid)IBA 09/2003
1	Histocompatibility Antigens Class IIIBA 03/2002

Therapy/Procedure

4	Immunotherapy 11/2015 - 06/2010
3	Therapeutics 11/2018 - 06/2010
1	Transplantation 01/2005